Topical creams and gels can provide some pain relief during a gout flare, but they are not the standard first-line treatment for the condition. The most evidence-backed topical option is a prescription NSAID gel such as diclofenac, which has been shown to penetrate through the skin into joint tissue and fluid. Over-the-counter products containing menthol, capsaicin, or lidocaine can also take the edge off, though they work by dulling pain signals rather than addressing the intense inflammation that makes gout so excruciating. The reality is more interesting than a simple yes or no, because the science of getting anti-inflammatory drugs through the skin and into a gout-ravaged joint is an active and fast-moving area of research.
What the Official Guidelines Actually Recommend
The 2020 American College of Rheumatology guideline for gout management strongly recommends oral colchicine, oral NSAIDs, or glucocorticoids (taken by mouth or injected into the joint or muscle) as the go-to treatments when a gout flare strikes.1PubMed Central. 2020 American College of Rheumatology Guideline for the Management of Gout Topical treatments are not explicitly listed in those recommendations. That does not mean topical products are useless or that rheumatologists never suggest them. It means the large clinical trials that guidelines rely on have focused on systemic (whole-body) medications, and topical approaches for gout specifically have not accumulated enough high-quality trial data to earn a formal recommendation yet.
This gap between what the guidelines cover and what patients actually want is worth understanding. Many people with gout also have kidney disease, cardiovascular problems, or stomach issues that make oral NSAIDs risky. Colchicine has a narrow dosing window before it causes diarrhea. Corticosteroids carry their own baggage. So the question “is there something I can just rub on it?” is not just about convenience. For some people, a topical approach could be the only safe option left.
Topical NSAIDs and Whether They Actually Reach the Joint
The biggest skepticism about topical pain creams for any joint condition is simple: can the drug actually get through the skin and into the tissue where it matters? For gout, that means reaching the synovial fluid and the lining of the affected joint, where monosodium urate crystals trigger an intense inflammatory cascade.2PubMed Central. The Mechanism of the NLRP3 Inflammasome Activation and Pathogenic Implication in the Pathogenesis of Gout
The answer, at least for diclofenac, is yes. A pharmacokinetic study of topical diclofenac applied to osteoarthritic knees found measurable diclofenac in both synovial tissue and synovial fluid more than 12 hours after the last application. Tissue concentrations averaged about 1.6 ng/g and fluid concentrations about 2.3 ng/mL.3PubMed Central. Penetration of topical diclofenac into synovial tissue and fluid of osteoarthritic knees: a multicenter, randomized, placebo-controlled, pharmacokinetic study A separate trial using a diclofenac spray gel found even more striking results: tissue concentrations were roughly 10 to 20 times higher than plasma levels, meaning the drug was concentrating locally at the joint rather than flooding the bloodstream.4PubMed. Penetration of topical diclofenac sodium 4 % spray gel into the synovial tissue and synovial fluid of the knee: a randomised clinical trial An earlier study comparing knees treated with diclofenac gel against the opposite knee treated with placebo on the same patient confirmed significantly higher drug concentrations in the synovial fluid of the diclofenac-treated side.5PubMed Central. Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease
These studies were done in osteoarthritis patients, not gout patients specifically. That distinction matters because gout inflammation is driven by a different and often fiercer mechanism, involving urate crystals and a specific inflammatory pathway. But the basic question of whether a topical NSAID can physically reach joint tissue has been answered clearly enough to be encouraging. The drug gets there. Whether it gets there in sufficient quantities to tame a full-blown gout attack, where the inflammatory response is exceptionally aggressive, is less certain and has not been tested in large gout-specific trials.
The Safety Advantage That Makes Topical NSAIDs Especially Relevant for Gout
Gout is not just a joint disease. It travels with a constellation of other health problems, including high blood pressure, kidney disease, heart disease, and diabetes. Oral NSAIDs like ibuprofen and naproxen are effective for gout pain, but they carry real risks for the kidneys and cardiovascular system, and they can cause stomach bleeding. These risks are amplified in the exact population that tends to get gout.
Topical NSAID formulations produce far lower blood levels of the drug than oral versions. All NSAIDs carry the same boxed warnings about cardiovascular and kidney risks, but topical forms are widely considered to have a more favorable safety profile specifically because so little of the drug enters the general circulation.6Pain Medicine. Topical NSAID Formulations For a gout patient whose kidneys are already strained, or who takes blood pressure medication, applying diclofenac gel to a swollen big toe joint is a fundamentally different risk proposition than swallowing an oral NSAID three times a day. This safety profile is arguably the strongest practical reason to consider topical NSAIDs for gout, even in the absence of gout-specific efficacy trials.
Over-the-Counter Options That Do Not Need a Prescription
Walk into any pharmacy and you will find shelves of topical pain-relief products. Most of them fall into a few categories, and understanding how they work helps set expectations for what they can and cannot do during a gout flare.
Menthol-Based Products
Menthol is the active ingredient in products like Biofreeze, Icy Hot, and Tiger Balm. It works by activating a specific cold-sensing receptor called TRPM8 on nerve endings in the skin. Research has confirmed that TRPM8 is the principal pathway through which menthol produces pain relief: in animal studies, genetically removing this receptor completely abolished menthol’s analgesic effect, while other painkillers like acetaminophen continued to work normally.7PubMed Central. TRPM8 is the Principal Mediator of Menthol-induced Analgesia of Acute and Inflammatory Pain Menthol also acts as a counterirritant, initially stimulating pain receptors and then desensitizing them, which creates a cooling sensation that competes with pain signals heading to the brain.8PubMed. The role and mechanism of action of menthol in topical analgesic products
The honest assessment: menthol products can provide temporary comfort and make the skin overlying the joint feel less awful, but they are not treating the crystal-driven inflammation beneath the surface. Think of them as turning down the volume on pain signals, not addressing the source of the noise. During a gout flare, that volume reduction might make the difference between being able to tolerate a sheet draped over your foot and not, which is worth something even if it is not a cure.
Capsaicin Creams
Capsaicin, the compound that makes chili peppers hot, is available in over-the-counter creams at concentrations around 0.025% to 0.1%. It works through a process researchers describe as “defunctionalization” of the nerve fibers that transmit pain. Rather than simply depleting a single chemical messenger, capsaicin causes the pain-sensing nerve endings to temporarily lose their ability to fire, retract from the skin surface, and stop transporting the growth factors they need to function.9PubMed Central. Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch This effect is reversible, but it takes repeated applications over days or weeks to build up.
That buildup period is a significant limitation for gout. A flare can peak within 12 to 24 hours and often resolves within a week or two. Capsaicin needs consistent, repeated use to become effective, and the initial applications actually burn and sting, which on an already agonizingly tender gout joint is not a pleasant prospect. Capsaicin may be more useful for people who get frequent flares in the same joint and want to use it between attacks to keep pain sensitivity low, rather than as a rescue treatment during a flare.
Lidocaine Patches and Gels
Topical lidocaine at 5% concentration, available as patches or gels, has been shown to relieve pain with a fast onset, typically within about 30 minutes, lasting for as long as the product stays in contact with the skin.10Oxford Academic. Targeting novel peripheral mediators for the treatment of chronic pain Lidocaine is a local anesthetic: it blocks nerve signals in the area where it is applied. Like menthol, it does not reduce the underlying inflammation, but it can numb the area enough to provide meaningful relief. The prescription-strength 5% lidocaine patch (Lidoderm) is FDA-approved only for postherpetic neuralgia, not gout, so using it for a gout flare would be off-label. Over-the-counter lidocaine products come in lower concentrations (around 4%) and are marketed for general pain relief.
Why Gout Is a Uniquely Difficult Target for Topical Treatment
Gout flares are driven by monosodium urate crystals physically depositing in and around joint tissue, which triggers a specific inflammatory cascade involving the NLRP3 inflammasome and the release of powerful inflammatory signaling molecules like IL-1β.2PubMed Central. The Mechanism of the NLRP3 Inflammasome Activation and Pathogenic Implication in the Pathogenesis of Gout This is not the dull, slow-burn inflammation of osteoarthritis. It is an acute, aggressive immune response that can make a joint swell, redden, and become exquisitely tender within hours. The intensity of the inflammation is one reason topical treatments that work well enough for a sore knee after a run may not fully control a gout flare.
There is also a geometry problem. The most commonly affected joint in gout is the first metatarsophalangeal joint, the base of the big toe. This is relatively superficial, which is good news for topical drug penetration. But when gout hits the ankle, knee, or wrist, the joint sits deeper beneath layers of tissue, and the path for a topically applied drug to reach the inflamed synovium is longer and more obstructed. The effectiveness of any topical product likely varies depending on which joint is involved.
Experimental Topical Approaches in Research
One intriguing research direction involves topical formulations that do not just reduce pain but could help dissolve the urate crystals that trigger flares in the first place. A study testing various commercial and experimental topical gels found that certain formulations could increase the solubility of monosodium urate by roughly 20% to 26% compared to controls, meaning the crystals dissolved more readily in the presence of the topical product.11PubMed Central. Testing Topical Products Specifically to Reduce Inflammatory Pain from Gout: Transdermal NSAID Delivery and Monosodium Urate Solubility That study also measured how much NSAID actually crossed full-thickness skin, finding ibuprofen delivery ranging from about 549 to 2,963 micrograms and diclofenac delivery from about 64 to 220 micrograms over 72 hours, depending on the formulation.11PubMed Central. Testing Topical Products Specifically to Reduce Inflammatory Pain from Gout: Transdermal NSAID Delivery and Monosodium Urate Solubility This is early-stage work, but the idea of a topical product that both delivers an anti-inflammatory and helps dissolve crystals is exactly the kind of dual-purpose treatment gout patients need.
Another frontier is lipid-based nanocarrier systems designed to push drugs through the skin barrier more efficiently. These tiny fat-based delivery vehicles can improve the solubility and bioavailability of drugs that are otherwise hard to absorb through the skin, and they can be engineered for sustained release at the application site with minimal systemic exposure.12PubMed Central. Gouty Arthritis Treatment: Advancements in Topical Lipid-Based Nanocarrier Delivery Systems In one animal study, allopurinol, a urate-lowering drug normally taken by mouth, was loaded into nanostructured lipid carriers and applied as a gel. The gel achieved roughly 28-fold higher skin permeation than a conventional gel and showed significantly better anti-gout activity in rats than oral allopurinol.13BMC Pharmacology & Toxicology. Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout If that translates to humans, the prospect of managing gout through a topical patch or gel rather than daily pills would be a genuine shift in treatment.
Traditional Herbal Topical Preparations
In parts of East Asia, topical herbal preparations have been used alongside conventional treatment for acute gout flares for decades. A systematic review and meta-analysis of herbal medicines applied externally for acute gouty arthritis found that the most commonly studied formulations, including Jinhuang powder, Shuangbai powder, and Zhihuang Zhitong powder, all appeared to reduce pain and swelling. The review noted that these preparations share several common ingredients, particularly rhubarb root and phellodendron bark, and appear to have overlapping effects on pain reduction, swelling, and inflammation.14PubMed Central. Herbal medicine for external use in acute gouty arthritis: A PRISMA-compliant systematic review and meta-analysis A randomized controlled trial of one such topical herbal compound applied to acute gout joints found significant reductions in pain scores and swelling compared to pretreatment levels.15PubMed Central. Effects of external application of compound Qingbi granules on acute gouty arthritis with dampness-heat syndrome: a randomized controlled trial
The evidence here is not strong enough to recommend these products over established treatments, and they are not readily available in most Western pharmacies. The trial quality in this area has been mixed, with many studies being small or lacking rigorous blinding. But the consistent signal across multiple formulations and studies suggests that some topical herbal ingredients may have genuine anti-inflammatory properties worth investigating further with better-designed trials.
Practical Advice for Using Topical Products During a Gout Flare
If you want to try a topical product for gout pain, a few practical points are worth keeping in mind. First, do not treat a topical cream as a replacement for systemic treatment during a severe flare unless your doctor has specifically told you that oral options are off the table. The inflammation in a major gout flare is intense enough that most topical products alone will not bring adequate relief. Think of topical treatments as something you layer on top of your main medication, not instead of it.
Second, the joint matters. A topical NSAID applied to the base of the big toe, where the joint sits just beneath the skin, is more likely to deliver meaningful drug concentrations than the same product applied over a deeper joint like the knee. If your gout tends to hit superficial joints, you are a better candidate for topical treatment.
Third, avoid applying topical products to broken or severely inflamed skin. Gout flares sometimes cause the skin over the joint to become so taut and irritated that it is essentially compromised. Applying a capsaicin cream or a menthol-based product to skin in that state can cause significant burning and irritation that makes things worse.
Fourth, if you are considering topical NSAIDs specifically because oral NSAIDs are risky for you due to kidney or heart problems, bring it up with your doctor rather than self-treating. Topical NSAIDs do produce lower systemic drug levels, but “lower” is not the same as “zero,” and in a person with advanced kidney disease, even small amounts of an NSAID entering the bloodstream may warrant monitoring.
What About Compounding Pharmacies
Some patients turn to compounding pharmacies that mix custom topical creams containing combinations of ingredients, such as an NSAID paired with a local anesthetic or a muscle relaxant. These products are not FDA-approved as finished combinations, and their efficacy and consistency vary. The appeal is obvious: a single cream that addresses both inflammation and nerve pain sounds ideal. The concern is that the formulations are not standardized, the drug concentrations are chosen by the prescriber rather than tested in clinical trials for that specific combination, and insurance rarely covers them. If a compounding pharmacy claims to have a proven gout cream, treat that claim with skepticism unless your rheumatologist specifically recommended that formulation.
The broader story here is that the topical treatment of gout is a space where the science is catching up to patient demand. People have been asking for something they can rub on a gout-swollen joint for as long as gout has existed. The tools are getting better, the delivery technology is advancing, and the safety advantages of keeping the drug local rather than systemic are especially compelling for the population most affected by gout. The large, definitive gout-specific trials of topical products have not been run yet, and until they are, topical treatments will remain an adjunct rather than a cornerstone of flare management.